Cargando…

Metaplasia in the Stomach Arises From Gastric Chief Cells

The development of intestinal-type gastric cancer is preceded by loss of parietal cells (oxyntic atrophy) and the induction of metaplastic cell lineages in the gastric mucosa. For example, mouse models have shown that spasmolytic polypeptide-expressing metaplasia can develop following oxyntic atroph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Jason C., Goldenring, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Point-Counterpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440355/ https://www.ncbi.nlm.nih.gov/pubmed/28560292 http://dx.doi.org/10.1016/j.jcmgh.2017.03.006

Ejemplares similares

Isthmus Stem Cells Are the Origins of Metaplasia in the Gastric Corpus
por: Hayakawa, Yoku, et al.
Publicado: (2017)

Rebuttal From Drs Pandian, Murgu, and Lamb
por: Pandian, Vinciya, et al.
Publicado: (2021)

The Esophageal Squamous Epithelial Cell—Still a Reasonable Candidate for the Barrett’s Esophagus Cell of Origin?
por: Wang, David H.
Publicado: (2017)

Barrett’s Stem Cells as a Unique and Targetable Entity
por: Xian, Wa, et al.
Publicado: (2017)

Rebuttal From Drs Brenner, Feller-Kopman, and De Cardenas
por: Brenner, Michael J., et al.
Publicado: (2021)

Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology?
por: Vandenbroucke, Jan, et al.
Publicado: (2015)

Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
por: Riddle, Matthew C.
Publicado: (2010)

COUNTERPOINT: Tracheostomy in Patients With COVID-19: Should We Do It Before 14 Days? No
por: Pandian, Vinciya, et al.
Publicado: (2021)

Should Requirements for Nurses Be Relaxed During Health Emergencies?
por: Gardenier, Donald, et al.
Publicado: (2021)

Should Local Excision After Neoadjuvant Therapy Be Included in the National Guidelines for the Treatment of Locally Advanced Rectal Cancer?
por: Aref, Amr, et al.
Publicado: (2022)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013)

Origin of Barrett’s Epithelium: Esophageal Submucosal Glands
por: Garman, Katherine S.
Publicado: (2017)

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009)

Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
por: Mineo, Davide, et al.
Publicado: (2009)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
por: Kalantar-Zadeh, Kamyar
Publicado: (2012)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
por: Freedman, Barry I.
Publicado: (2012)

Response to commentary “Zinc is decreased in prostate cancer: an established relationship of prostate cancer!”
por: Banas, Agnieszka Maria, et al.
Publicado: (2010)

Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
por: Ceriello, Antonio
Publicado: (2010)

Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013)

“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
por: Holloszy, John O.
Publicado: (2013)

Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Insulin Analogs—Is There a Compelling Case to Use Them? No!
por: Davidson, Mayer B.
Publicado: (2014)

2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management
por: Terkelsen, Christian Juhl, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis
por: Golden, Sherita Hill, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations
por: Home, Philip D.
Publicado: (2013)

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
por: Malanda, Uriëll L., et al.
Publicado: (2013)

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users
por: Polonsky, William H., et al.
Publicado: (2013)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
por: Nauck, Michael A.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment
por: Umpierrez, Guillermo E., et al.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
por: Schwartz, Stanley, et al.
Publicado: (2013)

Advanced Imaging Tools Rather Than Hemodynamics Should Be the Primary Approach for Diagnosing, Following, and Managing Pulmonary Arterial Hypertension
por: Gerges, Mario, et al.
Publicado: (2015)

Vandenbroucke and Pearce Respond to “Incident and Prevalent Exposures and Causal Inference”
por: Vandenbroucke, Jan, et al.
Publicado: (2015)

PLEASE DON'T REGULATE MY INTERNALITIES
por: Mannix, Brian F., et al.
Publicado: (2015)

POINT: Tracheostomy in Patients With COVID-19: Should We Do It Before 14 Days? Yes
por: Brenner, Michael J., et al.
Publicado: (2021)

Transdisciplinarity: letting arts and science teach together
por: Burnard, Pam, et al.
Publicado: (2021)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Guiu, Jordi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ialh24p7d40jghilsicu00v5g5